MoneyWorks4Me

Bandaram Pharma Pack - Quaterly Results

14 Aug 2025 Evaluate
The sales is pegged at Rs. 7.57 millions for the June 2025 quarter. The mentioned figure indicates a decline of about -72.19% as against Rs. 27.22 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -2.69 millions as compared to Net Loss of Rs. -2.48 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 further decreased to -2.68% as compared to -2.47% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 7.57 27.22 -72.19 7.57 27.22 -72.19 122.28 148.39 -17.60
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.94 0.27 248.15
PBIDT -2.68 -2.47 8.50 -2.68 -2.47 8.50 1.91 1.87 2.14
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -2.68 -2.47 8.50 -2.68 -2.47 8.50 1.91 1.87 2.14
Depreciation 0.01 0.01 0.00 0.01 0.01 0.00 0.06 0.15 -60.00
PBT -2.69 -2.48 8.47 -2.69 -2.48 8.47 1.85 1.72 7.56
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.45 0.43 4.65
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
PAT -2.69 -2.48 8.47 -2.69 -2.48 8.47 1.40 1.29 8.53
Equity 120.00 120.00 0.00 120.00 120.00 0.00 120.00 120.00 0.00
PBIDTM(%) -35.40 -9.07 290.15 -35.40 -9.07 290.15 1.56 1.26 23.95
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..